Jupiter Neurosciences, Inc. Common Stock (JUNS) — Financial Flexibility Index
Jupiter Neurosciences, Inc. Common Stock (JUNS) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-2.37 Million (operating CF $-2.37 Million minus capex $0.00) represents 0% of total liabilities ($7.40 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jupiter Neurosciences, Inc. Common Stock Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jupiter Neurosciences, Inc. Common Stock across 7 annual periods. See Jupiter Neurosciences, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jupiter Neurosciences, Inc. Common Stock (2019–2025)
Year-by-year free cash flow to debt coverage for Jupiter Neurosciences, Inc. Common Stock. For the full company profile including market capitalisation, see JUNS company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.73x | $-5.41 Million | $-5.41 Million | $7.40 Million | ▲ +62.0% |
| 2024 | -1.93x | $-3.91 Million | $-3.91 Million | $2.03 Million | ▼ -2283.0% |
| 2023 | -0.08x | $-480.95K | $-480.95K | $5.95 Million | ▲ +52.2% |
| 2022 | -0.17x | $-1.25 Million | $-1.25 Million | $7.38 Million | ▲ +43.0% |
| 2021 | -0.30x | $-1.74 Million | $-1.74 Million | $5.85 Million | ▼ -396.4% |
| 2020 | -0.06x | $-254.78K | $-254.78K | $4.26 Million | ▼ -110.1% |
| 2019 | -0.03x | $-142.95K | $-142.95K | $5.02 Million | — |